Experts
Check out the latest news, insights and unique analysis brought to you by Stockhead's team of business journalists and industry experts on Rhinomed.
RELATED STOCKHEAD STORIES
Health & Biotech
Weed Week: Good news from the TGA, but Australia’s CBD industry still lags the global pack
News
Closing Bell: Today’s biggest small cap movers on the ASX
Health & Biotech
Rhinomed soars after company develops new virus nasal swab
Health & Biotech
Weed Week: Moves are afoot in the US to fix a cannabis ‘scheduling’ clash
News
Rise and Shine: What you need to know before the ASX opens
News
Rise and Shine: What you need to know before the ASX opens
Health & Biotech
Scale-up secret sauce: These are the ingredients for medtech growth
Health & Biotech
Health Kick Podcast: Increasing athletic performance and fighting sleep apnea with a simple nose clip
News
Weed Week: COVID-19 drags on sentiment as ASX-listed pot stocks go 0/33
Health & Biotech
The US legal pot market is massive and confusing: report
Health & Biotech
Air pollution is expected to get worse, but these small caps are trying to help and they just might benefit
Health & Biotech
Weed week: Canberra leads the way on cannabis, makes pot possession legal
Tech
Rhinomed shares shoot up 40pc as it tops up coffers, mulls new cannabis products
News
Lunchtime ASX small cap wrap: Who’s shocking everyone today?
Health & Biotech
Health: Immutep bounces off decade-long lows thanks to cash from GSK
News
Rise & Shine: What you need to know before the ASX opens
News
